Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $4.2 million.

  • Sensus Healthcare's Cost of Revenue rose 1589.33% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 1474.12%. This contributed to the annual value of $17.4 million for FY2024, which is 6796.52% up from last year.
  • Latest data reveals that Sensus Healthcare reported Cost of Revenue of $4.2 million as of Q3 2025, which was up 1589.33% from $4.4 million recorded in Q2 2025.
  • Sensus Healthcare's Cost of Revenue's 5-year high stood at $6.0 million during Q4 2024, with a 5-year trough of $1.5 million in Q1 2021.
  • Over the past 5 years, Sensus Healthcare's median Cost of Revenue value was $3.8 million (recorded in 2024), while the average stood at $3.5 million.
  • As far as peak fluctuations go, Sensus Healthcare's Cost of Revenue surged by 20904.37% in 2021, and later crashed by 5010.46% in 2023.
  • Over the past 5 years, Sensus Healthcare's Cost of Revenue (Quarter) stood at $4.2 million in 2021, then rose by 14.03% to $4.8 million in 2022, then decreased by 0.38% to $4.7 million in 2023, then increased by 25.84% to $6.0 million in 2024, then crashed by 30.02% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $4.4 million for Q2 2025, and $4.0 million during Q1 2025.